Atlas Trials

Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma

Clinical trial NCT07326033 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07326033
Sponsor
University Hospital, Toulouse
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Scleroderma
Start date
2026-01-01
Primary completion
2028-04-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.